⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 4, 2026Molecular Therapy — Nucleic AcidsOpen Access

Complex HBB gene editing outcomes revealed by a fluorescent reporter cell model

Cécile Karsenty Daniel Betancourth Mingming Cao Quoc-Khanh Pham So Yeon Park Gang Bao

View Full Paper

Ask AI

Bookmark

Share

Key Points

Genetic outcomes were assessed using fluorescent markers, highlighting complex integration patterns in the HBB gene.
In this fluorescence-based analysis, significant variability in chromosomal integration of the HBB gene was recorded across multiple experiments.
The assessment utilized a fluorescent reporter cell model, allowing for detailed visualization of gene editing effects on HBB.
These findings may enable improvements in targeted gene therapies, yet they emphasize the need for more extensive validation in other models.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Observational analysis reveals complex genetic outcomes in fluorescent reporter cell models, suggesting new insights into gene editing benefits.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Karsenty et al. (2026) studied this question.

synapsesocial.com/papers/69a76046c6e9836116a2cda7 https://doi.org/10.1016/j.omtn.2026.102854

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021Original Research · 2023 · 759 citations
2Bone Marrow Transplantation for Sickle Cell DiseaseOriginal Research · 1996 · 624 citations
3CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-ThalassemiaOriginal Research · 2020 · 1,953 citations
4High-level correction of the sickle mutation is amplified in vivo during erythroid differentiationOriginal Research · 2022 · 54 citations
5Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell diseaseOriginal Research · 2019 · 148 citations

Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease2021
CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity2013
Modulation of the microhomology-mediated end joining pathway suppresses large deletions and enhances homology-directed repair following CRISPR-Cas9-induced DNA breaks2024
Beyond repressor disruption: Designing activator motifs to boost fetal hemoglobinMolecular Therapy — Nucleic Acids · 2026
AAV encoding miRNAs as a new therapeutic for choroidal neovascularizationMolecular Therapy — Nucleic Acids · 2026

More from Molecular Therapy — Nucleic Acids

More from Rice University

More from Children's Cancer Center